Conditions: Multiple Sclerosis Interventions: Other: Acupuncture; Other: Conventional Rehabilitation Sponsors: Ankara City Hospital Bilkent Recruiting Clinical Trials online
Category: Conditions
General news and information about conditions and diseases
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Conditions: Multiple Sclerosis (MS) Interventions: Drug: elezanumab; Drug: placebo Sponsors: AbbVie Completed Clinical Trials online
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis
Conditions: Multiple Sclerosis (MS) Interventions: Drug: elezanumab; Drug: placebo Sponsors: AbbVie Completed Clinical Trials online
Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)
Conditions: Relapsing-Remitting Multiple Sclerosis Sponsors: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany; Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, Germany Completed Clinical Trials online
Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies
Conditions: Multiple Sclerosis Interventions: Other: Ofatumumab Sponsors: Novartis Pharmaceuticals Active, not recruiting Clinical Trials online
Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS®
Conditions: Multiple Sclerosis (MS) Interventions: Other: Neurostatus-SMARTCARE; Other: Standard Neurostatus-EDSS Sponsors: University Hospital, Basel, Switzerland; Novartis Pharma AG, Basel, Switzerland Active, not recruiting Clinical Trials online
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients
Conditions: Multiple Sclerosis Interventions: Other: Blood sample collection Sponsors: German University in Cairo Active, not recruiting Clinical Trials online
Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
Conditions: Multiple Sclerosis (MS); Relapsing Remitting Multiple SclerosisInterventions: Drug: ANK-700; Drug: PlaceboSponsor: Anokion SARecruiting Clinical Trials online
The Relationships Between Personal Identity, Autobiographical Memory and Future Thinking in People With Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting; Healthy ControlsIntervention: Behavioral: Neuropsychological tests and psychological questionnairesSponsors: Centre d’Investigation Clinique et Technologique 805; University Paris 8 Vincennes Saint Denis; ARSEP foundationRecruiting Clinical Trials online
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Drug: OcrelizumabSponsor: Hoffmann-La RocheRecruiting Clinical Trials online
Development and Validation of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Device: Eye-TrackingSponsors: Innodem Neurosciences; NovartisRecruiting Clinical Trials online
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
Condition: Multiple SclerosisIntervention: Sponsors: University of Colorado, Denver; EMD Serono; National Multiple Sclerosis SocietyCompleted Clinical Trials online